IIT Madras has launched a new research centre on Diabetes to drive advancements in diabetes research and develop innovative technologies to address the most pressing challenges in diabetes care and associated complications.
This centre has been supported by generous funding from IIT Madras Distinguished Alumnus Awardee Mr. Subramonian Shankar (1971 – B.Tech – Electrical Engineering).
The ‘Shankar Center of Excellence for Diabetic Research’ (SCoEDR) was inaugurated on 20 September 2024 at the Department of Medical Sciences and Technology (DMST), IIT Madras.
The others present were Prof. V. Kamakoti, Director, IIT Madras, Mr. Chris Hodges, U.S. Consul General, Chennai, Mr. Subramonian Shankar, CEO and Founder, AmZetta Technologies, LLC, Prof. Ashwin Mahalingam, Dean-Designate (Alumni and Corporate Relations), IIT Madras, and other dignitaries.
Prof. V. Kamakoti, Director, IIT Madras spoke during the launch event.
The ‘Shankar Center of Excellence for Diabetic Research’ has come at a very important juncture when we are building the Department of Medical Science and Technology, he said.
The objective of the Department is to see how technology can intervene to either prevent an illness or diagnose quickly and treat the illness, he said.
With diabetes being one of the most prevalent illness in the country, the outcome of this joint activity that will happen in this centre of excellence will be of great societal and national importance, said IIT Madras director.
Delivering the chief guest address, Mr. Chris Hodges, U.S. Consul General, Chennai, said it is stunning to see the amount of intellectual genius every time I come here.
On treating diabetes, you are talking about isolating variables in a challenging environment, he said.
It is satisfying to see the partnership between two leaders – IIT Madras and Emory Global Diabetes Research Center (EGDRC) at Emory University, U.S – come together and even greater to see members of the Indian Diaspora in the U.S. like Mr. Subramonian Shankar lead such initiatives, he said.
The chief guest further said he would like to see more research partnerships with American universities and see American students and faculty undertake research here at IIT Madras.
This would not just be an opportunity to further research but also learn about each other, he said.
I can, and my team, connect these students and faculty with the research opportunity here at Chennai. We can also connect them to business and see start-ups come out of IIT Madras, he said.
‘I want to see these businesses connect to American businesses. I want to see academic research drive business opportunities.’
The Center will support 15 PhD students over the coming years as ‘Shankar Fellows’, enabling them to undertake cutting-edge research, say sources from IIT Madras.
The new Centre will also foster product development, potential start-ups, and commercialization efforts aimed at transforming diabetes management and treatment, say sources from IIT Madras.
IIT Madras Distinguished Alumnus Mr. Subramonian Shankar, CEO and Founder, AmZetta Technologies, LLC, said, “I came to know of a Centre at Emory University that was working on diabetes.
‘What stuck me about this centre was that It was a research facility and in my entire life, I have been a research and development person.’
This Centre was publishing hundreds of papers a year but all academic with not much going to the industry and applying the research for the bettering of human health condition, he said.
Being a entrepreneur, I suggested to the Centre that his work can be applied to the industry and offered to work with him on this aspect. The Emory University agreed to my suggestions, he said.
He further said at the same time, being an alumnus, I was visiting IIT Madras a few times.
What struck me about IIT Madras was the focus on entrepreneurship and how it was developing start-ups through the Research Park and Incubation Cell.
Hence, the best thing I thought was to get IIT Madras and Emory University together, he said.
After I learnt about the Department of Medical Sciences and Technology at IIT Madras along with the entrepreneurship activities of the Institute, the rest, as they say, is History. Last year, it was all on paper, he said.
This year, everything is in place. From the way things are developing, a lot more is going to happen in the future, he said.
I am sure with the brains that exist at IIT Madras and the kind of research that happens at Emory, the results are a foregone conclusion. I am sure we will see great results, he said.
Thanking Mr. Subramonian Shankar for his generous contribution, Prof. Mahesh Panchagnula, Dean (Alumni and Corporate Relations), IIT Madras, said, the alumni community of IIT Madras have always stepped up to support the various research initiatives at the Institute.
Our Distinguished Alumnus Awardee, Mr Subramaniam Shankar’s continued support to the institute and especially in the setting up of the Shankar Centre of Excellence for Diabetes Research Centre is truly commendable and we are grateful for his support and encouragement, he said.
As part of its mission, SCoEDR established a strategic partnership between IIT-Madras and the Emory Global Diabetes Research Center (EGDRC) at Emory University, U.S.
This collaboration will enable joint research initiatives, knowledge exchange and expertise-sharing in diabetes research, combining the strengths of both institutions in biomedical innovation and public health.
Also Read – Top 21 IITs in India in 2024: NIRF 2024 Ranking
The EGDRC is recognized for its pioneering global initiatives aimed at preventing and treating diabetes through interdisciplinary research, education, and public health outreach.
S Vishnu Sharmaa now works with collegechalo.com in the news team. His work involves writing articles related to the education sector in India with a keen focus on higher education issues. Journalism has always been a passion for him. He has more than 10 years of enriching experience with various media organizations like Eenadu, Webdunia, News Today, Infodea. He also has a strong interest in writing about defence and railway related issues.
14 Oct, 2024
10 Oct, 2024
7 Oct, 2024
4 Oct, 2024
12 Aug, 2024
12 Aug, 2024
11 Aug, 2024
11 Aug, 2024
10 Aug, 2024